Profound Medical Corp.
NASDAQ:PROF
Overview | Financials
Company Name | Profound Medical Corp. |
Symbol | PROF |
Currency | USD |
Price | 7.38 |
Market Cap | 221,610,330 |
Dividend Yield | 0% |
52-week-range | 6.78 - 11.42 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Arun Swarup Menawat MBA, Ph.D. |
Website | https://www.profoundmedical.com |
An error occurred while fetching data.
About Profound Medical Corp.
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD